Travere Therapeutics Executives Sell Shares Amid Market Volatility

Travere Therapeutics, Inc. (TVTX) has announced that several of its top executives have sold shares of the company. Specifically, SVP and Chief Accounting Officer Calvin Sandra sold 4,333 shares at $32.12 per share on February 3, 2026. Chief Financial Officer Cline Christopher R. sold 7,242 shares at the same price on the same day. Director and Chief Executive Officer Eric M. Dube sold 66,452 shares at $32.06 per share on February 3, 2026, while also selling 33,635 shares at $32.7 per share on the same date. Chief Commercial Officer Peter Heerma sold 7,310 shares at $32.12 per share on February 3, 2026, as did Chief Medical Officer Jula Inrig, who sold 6,956 shares at the same price on the same day. Chief Legal Officer and General Counsel Elizabeth E. Reed sold 7,175 shares at $32.12 per share on February 3, 2026, and Chief Research Officer William E. Rote sold 12,446 shares at $32.87 per share on the same date.